Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind Extension Study To Assess The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

NCT00848549 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00848549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00848549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind Extension Study To Assess The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2008
Completion date
November 30, 2011
Enrollment
295 (actual)
Sites
133

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy